According to Accelerate Diagnostics's latest financial reports and stock price the company's current number of shares outstanding is 14,433,000. At the end of 2023 the company had 14,433,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 14.43 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 387,000,000 | 2,581.36% | ๐บ๐ธ USA |
Becton Dickinson BDX | 290,113,000 | 1,910.07% | ๐บ๐ธ USA |
PerkinElmer
PKI | 126,285,000 | 774.97% | ๐บ๐ธ USA |
Bruker BRKR | 145,500,000 | 908.11% | ๐บ๐ธ USA |
NanoString Technologies NSTG | 47,715,000 | 230.60% | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | 29,102,000 | 101.64% | ๐บ๐ธ USA |